# Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis

> **NCT06256575** · NA · RECRUITING · sponsor: **Primus Pharmaceuticals** · enrollment: 45 (estimated)

## Conditions studied

- Scleroderma, Systemic
- Digital Ulcer

## Interventions

- **COMBINATION_PRODUCT:** Diosmin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06256575
- **Lead sponsor:** Primus Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-02
- **Primary completion:** 2027-07-15
- **Final completion:** 2027-08-15
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2025-12-04

## Collaborators

- KGK Science Inc.

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06256575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06256575, "Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT06256575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*